|
1
|
Kamisawa T, Funata N, Hayashi Y, Eishi Y,
Koike M, Tsuruta K, Okamoto A, Egawa N and Nakajima H: A new
clinicopathological entity of IgG4-related autoimmune disease. J
Gastroenterol. 38:982–984. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stone JH, Zen Y and Deshpande V:
IgG4-related disease. N Engl J Med. 366:539–551. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yamamoto H, Yamaguchi H, Aishima S, Oda Y,
Kohashi K, Oshiro Y and Tsuneyoshi M: Inflammatory myofibroblastic
tumor versus IgG4-related sclerosing disease and inflammatory
pseudotumor: A comparative clinicopathologic study. Am J Surg
Pathol. 33:1330–1340. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Moriarty MA, Dahmoush L and Nepple KG:
IgG4 related disease of the ureter (inflammatory pseudotumor). J
Urol. 191:1126–1127. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Saeki T and Kawano M: IgG4-related kidney
disease. Kidney Int. 85:251–257. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tsubata Y, Akiyama F, Oya T, Ajiro J,
Saeki T, Nishi S and Narita I: IgG4-related chronic
tubulointerstitial nephritis without autoimmune pancreatitis and
the time course of renal function. Intern Med. 49:1593–1598. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kuroda N, Nao T, Fukuhara H, Karashima T,
Inoue K, Taniguchi Y, Takeuchi M, Zen Y, Sato Y, Notohara K and
Yoshino T: IgG4-related renal disease: Clinical and pathological
characteristics. Int J Clin Exp Pathol. 7:6379–6385.
2014.PubMed/NCBI
|
|
8
|
Tan TJ, Ng YL, Tan D, Fong WS and Low AS:
Extrapancreatic findings of IgG4-related disease. Clin Radiol.
69:209–218. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kamisawa T, Okazaki K, Kawa S, Shimosegawa
T and Tanaka M: Research Committee for Intractable Pancreatic
Disease and Japan Pancreas Society: Japanese consensus guidelines
for management of autoimmune pancreatitis: III. Treatment and
prognosis of AIP. J Gastroenterol. 45:471–477. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Saeki T, Kawano M, Mizushima I, amamoto M,
Wada Y, Nakashima H, Homma N, Tsubata Y, Takahashi H, Ito T, et al:
The clinical course of patients with IgG4-related kidney disease.
Kidney Int. 84:826–833. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mizushima I, Yamada K, Fujii H, Inoue D,
Umehara H, Yamagishi M, Yamaguchi Y, Nagata M, Matsumura M and
Kawano M: Clinical and histological changes associated with
corticosteroid therapy in IgG4-related tubulointerstitial
nephritis. Mod Rheumatol. 22:859–870. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dhobale S, Bedetti C, Killian P, Ilyas M,
Liput J, Jasnosz K and Giclas P: IgG4 related sclerosing disease
with multiple organ involvements and response to corticosteroid
treatment. J Clin Rheumatol. 15:354–357. 2009. View Article : Google Scholar : PubMed/NCBI
|
